List of Ongoing Projects

Responsive Table
SN. PROJECT TITLE PRINCIPAL INVESTIGATOR CO-INVESTIGATOR FUNDING AGENCY STARTING DATE COMPLETION DATE
1 Long-lasting treatments for nets and spraying Franklin Mosha Mark Rowland, Richard Oxborough IVCC Sept. 2011 Sept. 2021
2 Phase III Evaluation of Dawa Plus 2.0 Franklin Mosha Mark Rowland, Richard Oxborough WHOPES Sept. 2011 Sept. 2021
3 Genetic Susceptibility to scarring Trachoma Mathew Burton Athuman Mchana LSHTM, Wellcome Trust Aug. 2011 Aug. 2021
4 The Immunological Determinants of Protective Immunity and Immunopathology Mathew Burton Athuman Mchana LSHTM, Wellcome Trust Aug. 2011 Aug. 2021
5 Determining the prevalence of alcohol intoxication and high-risk alcohol behavior amongst adult injury patients at KCMC Blandina Mmbaga Catherine Lynch, Charles Gerrardo, Nathan Thielman NIH June, 2012 Ongoing
6 Impact and ecology of bacterial zoonoses in Northern Tanzania Blandina Mmbaga Kazwala, John Crump NIH Aug. 2014 Aug. 2021
7 Knowledge, attitude, and practice of health care practitioners at KCMC on at-risk alcohol behavior amongst their patients Blandina Mmbaga Catherine Lynch, Charles Gerrardo, Neel Kapadia NIH Aug. 2012 Ongoing
8 Establishing Mental Health Needs in HIV Positive Adolescents in Tanzania Aisa Shayo Ann Buchanan, Dorothy Dow Duke Pediatric Infectious Clinic Aug. 2012 Ongoing
9 Identification and Intervention for people with Dementia in Africa (IDEA Study) Declare Mushi Adesola Ogunniyi, Richard Walker, Sarah Mkenda Grand Challenges Canada May, 2013 Ongoing
10 Evaluation of a novel long-lasting insecticidal and indoor residual spray product, separately and together, against malaria transmitted by parathyroid resistant mosquitoes Franklin Mosha William Kisinza, Mark Rowland, Natacha Protopopoff Medical Research Council and Welcome Trust April, 2015 Ongoing
11 Unraveling the role of interleukin 32 in HIV related Kaposi Sarcoma George Semango Gibson Kibiki COSTECH Oct. 2014 Ongoing
12 Assessment of prevention of mother to child HIV transmission program among fishing communities of Lake Victoria in Tanzania Maseke Mgabo Sia Msuya, Declare Mushi Institute of Rural Development and Planning November, 2014 Ongoing
13 IMPAACT P1093: Phase 1/11, Multicentre, Open-label, Pharmacokinetic, Safety, tolerability and antiviral activity of GSK 1349572, a novel integrase inhibitor in combination regimens in HIV-1 infected infants, children, and adolescents Blandina Mmbaga James Ngocho, Boniface Njau, Coleen Cunningham The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIAD) 16th April, 2015 2021
14 Integrating Mental Health into an HIV clinic to improve outcomes among Tanzania Blandina Mmbaga Aisa Shayo, Dr. Dorothy Dow US National Institute of Health and Fogarty International June, 2015 June, 2021
15 HIV testing Preferences in Tanzania Bernard Njau Jan Ostermann, Nathan Thielman National Institute of Allergy and Infectious Disease 15th December, 2011 Ongoing
16 Esophageal Squamous cell carcinoma African Preventive Effort (ESCAPE) Tanzania Blandina Mmbaga Amos Mwasamaja ESCAPE Jun-16 Ongoing
17 A Phase IV Randomized Trial to Evaluate the Virologic response and pharmacokinetics of two different potent regimens in HIV Infected women initiating triple antiretroviral regimens between 28 and 36 weeks of pregnancy for the prevention of mother to child transmission: NICHD P1081 Version Dated 2nd April 2015 Blandina Mmbaga James Ngocho The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIAD) June, 2015 June, 2021
18 A5300/IMPAACT 2003 PHOENix Feasibility Study of MDRTB cases and their household contact: Operational feasibility to inform PHOENix Trial Design Blandina Mmbaga James Ngocho and Boniface Njau US National Institute of Health December, 2015 December, 2021
19 P1097 Raltegravir pharmacokinetics and safety in neonates, version 2.0 dated 22nd January 2014 Blandina Mmbaga James Ngocho, Boniface Njau, Coleen Cunningham US National Institute of Health October, 2015 October, 2021
20 Evaluation of Portable Eye Examination Kit (PEEK) for the diagnosis of diabetic retinopathy in Kilimanjaro Region Tanzania William Makupa Mathew Burton, Heiko Phillipin, Christopher Mwansanso, Japhet Bright and Tara Mtuy LSHTM Mar-16 Mar-21
21 Kilimanjaro Microbial Keratitis Study William Makupa Muna Elisante, Athuman Ramadhani, Heiko Philipin, Japhet Bright, Tara Mtuy, Joshua Wilkes LSHTM Mar-16 Mar-21
22 Factors influencing effective linkage of newly diagnosed HIV/AIDS client from point of testing to care and treatment clinics in Tanga region, Tanzania Maseke Mgabo Oasis Lunyera, Mussa Mapunda Tanzania Medical Research Institute April, 2015 May, 2021
23 Prevalence and risk factors for peripheral neuropathy in HIV infected patients at KCMC Aisa Shayo George Semango, Blandina Mmbaga KCMC Research Fund Jan, 2017 Jan, 2022
24 Maternal and Child Health Intervention in Preventing HIV Transmission Maseke Mgabo Nina Burrows, Sia Msuya USAID Feb, 2018 Ongoing
25 Investigating the role of genetic predisposition in chronic diseases in Tanzanian populations Nashon Nyundo Emanuel Ngowi, Teresa Mkoma NIH Mar, 2018 Mar, 2023
26 The role of traditional medicine in management of malaria in rural Tanzania John Makunde Fiona McDonald Global Health Fund Jun, 2019 Jun, 2024
27 Evaluation of a community-based mental health intervention for people with depression in Tanzania Peter Mbewe Adesola Ogunniyi Wellcome Trust Aug, 2020 Aug, 2025
28 Impact of digital health on chronic disease management in rural Tanzania Elisha Luvanda Nashon Nyundo, Edna Temba Tanzania Development Fund Nov, 2020 Nov, 2023
29 Evaluating the effectiveness of mobile health interventions for maternal health education in Tanzania Benjamin Kamugisha Richard Walker, Sarah Mkenda Bill and Melinda Gates Foundation Jan, 2021 Jan, 2026
30 Prevalence of non-communicable diseases in HIV patients on ART in Tanzania Aisa Shayo Mathew Burton, Lucy Kilonzo Tanzania Ministry of Health Mar, 2021 Mar, 2026
31 Investigating the impact of climate change on waterborne diseases in Tanzania Emmanuel Ruhu Josphat Kiplangat, Helen Mnyamwezi World Bank Jun, 2021 Jun, 2026
32 Examining the association between air pollution and respiratory diseases in Dar es Salaam Nashon Nyundo Anastasia Mwijarubi, Charles Mchome UK Aid Sep, 2021 Sep, 2024
33 Assessing the role of nutrition in preventing childhood malnutrition in Tanzania Elinaza Mzava Sarah Mzuri, Tuma Bonga UNICEF Dec, 2021 Dec, 2026
34 Understanding the impact of mental health stigma on treatment adherence in Tanzania Alice Mtui Michael Gidwani, Jenny Kiwia Global Fund Jan, 2022 Jan, 2025
35 Assessing the role of public health education in reducing the burden of malaria in rural Tanzania John Makunde Philip Ramadhan, Lydia Mlawa CDC Mar, 2022 Mar, 2026
36 Examining the socio-economic impact of HIV/AIDS on vulnerable populations in Tanzania Sidi Mwalimu Gideon Zuberi, Salome Nkosi African Development Bank Apr, 2022 Apr, 2027
37 Improving maternal health care services in rural regions of Tanzania Theresa Mkoma Harold Mzuri, Cecilia Kipele DFID Jun, 2022 Jun, 2025
38 Assessment of vaccination coverage and its impact on reducing preventable diseases in Tanzania Zelda Mnyamwezi Philip Beshim, Samwel Nduli WHO Aug, 2022 Aug, 2027
39 Evaluation of HIV prevention programs targeting adolescents in Tanzania Frida Gidwani Naomi Shayo, Melita Mkoji UNAIDS Nov, 2022 Nov, 2025
40 Role of sanitation and hygiene practices in preventing waterborne diseases in Tanzania Lilian Mvungi Gustavo Murudi, Elina Sanga WaterAid Feb, 2023 Feb, 2026
41 Investigating the economic impact of healthcare service delivery on Tanzania’s rural populations Sylvia Komba Derrick Mkama, Sophia Kitulo Tanzania Health Trust Apr, 2023 Apr, 2028
42 Examining the effectiveness of digital technologies in enhancing patient care in Tanzanian hospitals Stephen Nguvumali Timothy Ndula, Monica Kisaya Tanzania Ministry of Health May, 2023 May, 2028
43 Assessing the impacts of COVID-19 on mental health in Tanzania’s healthcare workers Julius Kitindi Linda Mnyamwezi, Joshua Boda CDC Jul, 2023 Jul, 2026
44 Translation research into policy and practice: Scaling up evidence-based multiple focus integrated intensified TB screening to end TB (EXIT TB) in the East African region Blandina Mmbaga Esther Ngadaya, Sayoki Godfrey Mfinanga, Godfather Dickson Kimaro, Sokoine Kivuyo, Mbazi Senkoro, Amosi Kahwa, Ramadhani Shemtandulo, Godbless Charles Mbua, Bernard Ngowi, Sara Moses Marwerwe, Hadija Hamisi Semvua Ongoing
45 Pyrethroid resistance PBO impregnated blankest for control on malaria in a humanitarian emergency situation Jovin Kitau Franklin Mosha, Joyce Wamoyi, Natacha Protopopoff Ongoing
46 Scale-up dementia screening and low resource interventions for dementia in older adults /depe study Sarah Urasa Richard Walker, Declare Mushi, Irene Haule, Sarah Mkenda October, 2017 Ongoing
47 Phase III evaluation of fludora ®fusion 56.25 wp. sp(clothianidin 50% + deltamethrin 6.25%) for indoor residual spraying for malaria vector control in Muheza, N.E Tanzania Matt Kirby Mark Rowland, Franklin Mosha, William Kisinza LSHTM October, 2017 October, 2021
48 Effect of dietary nitrate and folate supplementation on blood pressure in hypertensive Tanzanians. A feasibility study Gloria Temu Blandina Mmbaga, Declare Mushi New Castle University Ongoing
49 Streamlining ethics review process and regulatory framework in Tanzania SMERT Blandina Mmbaga Nyanda Elias Ntinginya, Ruby Mcharo, Kissa Mwamwita, Joyce Ikingura EDTCP Ongoing
50 An open-label partially randomized trial to evaluate the efficacy, safety, and tolerability of a 4-month treatment Bedaquiline plus moxifloxacin plus pyrazinamide (BPaMZ) compared to a 6-month treatment to HRZE/HR (Control) in adult participants with drug-sensitive smear-positive pulmonary tuberculosis (DS-TB) NC 008 (B-Pa-MZ) Trial- Simplici TB Blandina Mmbaga Elias Nyanda, Stella Mpagama, Hadija Semvua, Aliphonce Liyoyo, Peter Mmbelele EDTCP
51 IMPAACT P1092: Phase IV Evaluation of the steady-state pharmacokinetics of zidovudine, lamivudine, and lopinavir/ritonavir in severely malnourished HIV-1 Infected ARV-naïve children who are initiating HAART Aisa Shayo Boniface Njau, Ann Buchanan NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASE Jul-10 Jul-21
52 Effectiveness of prevention package and model for predicting metabolic risk factors of type 2 diabetes among street-cooked food consumers in Dar es Salaam. A cluster randomized controlled trial Gibson Kagaruki Micheal Mahande, Sayoki Mfinanga, Esther Ngadaya, Daniel Haydon Afrique One ASPIRE May-18 May, 2021
53 The holistic approach to unravel antibacterial resistance in East Africa (HATUA) Blandina Mmbaga EDTCP July, 2018 July, 2021
54 Pharmacovigilance in Africa Blandina Mmbaga Hadija Semvua, Stella Mpagama, Kennedy Ngowi, Adam Mitangu Fimbo EDTCP Jul-18 Jul-21
55 Health Professionals Education and Partnership Initiative (HEPI) Prof. Ephata Kaaya Kien A. Mteta, Pascalis Rugarabamu, John Bartlet NIH Aug. 2018 Aug. 2021
56 The effect and challenges of the implementation of differentiated HIV and AIDS service delivery in North-Eastern Tanzania Furaha Lyamuya Rachel Manongi, Eva Muro, and Terese Katzein BSU III Aug-18 Aug. 2021
57 Ondoilo: An increasing dialogue on family planning between Maasai and healthcare using interactive voice response calls Dr. Sumari Deboaer Kennedy Ngowi, Blandina Mmbaga, Benjamin Shayo, Martha Oshiosen, Godfrey A. Kisigo, Eusebius Maro, Jacquiline Kwayu Voice Global Jul-18 Aug. 2021
58 A prospective cohort study on the incidence and predictors of severe altitude illness symptoms in Mount Kilimanjaro Climbers Gissella Nyakunga Mieke Croughs, Blandina Mmbaga, Kajiru Gad Kilonzo, Francis Sakita, and Patrick Soentjens Institute of Tropical Medicine Belgium Aug-18 Aug. 2021
59 Randomized controlled noninferiority trial off topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in East Africa William Makupa Mathew Burton,Simon Arunga,Jeremy Hoffman,David Macleod,Helen Weiss,John Cairnes,Tara Mtuy,Tamsyn Derrick,Astrid Leck ,Paul Verweij Welcome Trust September,2018 Ongoing
60 Xeroderma pigmentation in Tanzania. Clinical presentation, subtype, and incidence of tumors in a hospital-based cohort David Mavura Gail Todd,Sia E.mMsuya Dec-18 December,2021
61 Determining the prevalence of disease other than tuberculosis in patients beginning treatment for smear-negative tuberculosis in patients beginning treatment for smear-negative tuberculosis Gissella Nyakunga December,2018 December,2021
62 Human papillomavirus self-sampling and the use of telepathology in scaling up cervical cancer control in Kilimanjaro region, Northern Tanzania Alexi Mremi Vibeke Rasch,Doris Schledermann BSU III December,2018 December,2021
63 Effectiveness and implementation of EVriMED for adherence to treatment among TB patients in Kilimanjaro Tanzania Marion Sumari Blandina Mmbaga,Francis Pima,Kennedy Ngowi,Hadija Semvua,Stella Mpagama,Benson Mosha,Manase Chelangwa,Isaya Jelly,Pythia Nieuwkerk,Rob Aarnoutse TB reach wave 6 Dec-18 Dec-21
64 Supporting the National Action Plan for AMR (SNAP-AMR) in Tanzania Blandina Mmbaga Elizabeth Msoka,Florida Muro,Stephen Mshana,Jeremiah Soni,Gabriel Shirima,Siana Mapunjo,Ruth Zadoks,Alicia Davis,Nick Hanley,Shona Hilton,Emma Laurie,Tiziana Lembo levi Antimicrobial resistance cross council(Medical Research Council and National Insitute for Health Research December,2018 December, 2021
65 Sexually transmitted infections and sexual behaviors among young adults attending higher learning institutions in Mbeya region, Tanzania Version 1.0, dated 12th July 2017 Ruby Doryn Mcharo Sia Msuya ,Phillipe Mayaud THRIVE-2 December,2018 Ongoing
66 Health care workers experiences of antibiotic prescription in children under five years, a qualitative study carried out in Moshi, Tanzania Matilda Emgrad Sia E.Msuya Centre of Antimicrobial resistance Research (CARe)Gothenburg University Sweden Mar-19 Mar-21
67 NIHR global health research group on estimating the prevalence quality of life economic and societal impact of arthritis in Tanzania Blandina Mmbaga Kajiiru Gad Kilonzo,Gloria Temu,Ireen Kiwelu,Elizabeth Msoka,Kiula Peter Kiula,Emma Sarah Mcintosh,I ain mclness,Sall Wyke,Dan Haydon,Sarah Cleveland,Stefan Sixbert,Jo Halliday,Christopher Bunn,Eleanor Grieve,Moira Aitken,Richard Wialker,Olive Kelly EDTCP Feb-19 February, 2021
68 Assessment of temporal changes in Malaria epidemiology use of human antibody responses to mosquito and parasite antigens in North-East Tanzania Nancy Abdul Kassam Reginald Kavishe,Micheal Alifrangis,Christian William Wang,Christence Schmiegelow BSU 111 FEB.2019 February, 2021
69 A5300B/12003B PhoENix Protecting households on exposure to newly diagnosed index Multidrug-resistant Tuberculosis Patients (PHOENix MDR TB) James Samwel Ngocho Aisa Shayo,Boniface Njau,Stella Mpagama,Dr.Hans Maro,Dr.Coleen Cunningham NICHD and NIAID March,2019 Mar-21
70 Silica and radon exposures and its associated effects on respiratory system among small scale Tanzanite miners in Mererani Alexander William Mbuya Hadija semvua,Simon Henry Mamuya,Sia Msuya DAAD Scholarship April,2019 April,2021
71 Open-label access to dolutegravir for HIV-1 infected children and adolescents completing IMPAACT study p1093 Blandina Mmbaga James Ngocho,Boniface Njau,Coleen Cunningham GSK
72 Determining the prevalence of disease other than tuberculosis in patients beginning treatment for smear-negative tuberculosis Gissella Nyakunga nil November, 2018 November, 2021
73 Active reporting of adverse drug reaction of antiretroviral drugs among adults living with HIV in East Africa: a pilot study on using SMS Marion Sumari Eva Muro, Blandina Mmbaga, Kennedy Ngowi EACCR/EDTCP May, 2019 May, 2021
74 Establishing and optimizing Illumina Miseq HIV-1 next-generation sequencing and drug resistance mutations testing at the KCRI biotechnology laboratory, Kilimanjaro region Happiness Kumburu Ireen Kiwelu, Blandina Mmbaga, John Bartlet, Marco Van Zwetselaar Duke University June, 2019 July, 2021
75 Diagnosing children and young adults with suspected lymphoma in East Africa: Comparison of conventional pathology with digital scans and liquid biopsies Elifurah aMkwizu Oliver Henke, Mramba Nyindo, Alexi Mremi, Furaha Serventi, Esther Majaliwa National Institute of Health Research June, 2019 July, 2021
76 Prevalence and characteristics of patients with chronic lymphocytic leukemia at a referral hospital in Tanzania. A hospital-based approach towards a hematologic malignancy in tropical Africa Oliver Henke Elifuraha Mkwizu, Mramba Nyindo, Furaha Servent, Mapendo Mwakipunda self funded June, 2019 July, 2021
77 Obtaining peripheral blood samples from HIV infected persons for standardization of virology quality assurance assays Philoteus Sakasaka Blandina Mmbaga, Mathew Rubach US National Institute of Health Jul-19 July, 2021
78 NOHA: an alternative to IHC in distinguishing ER – from ER+ breast cancer in the low resource setting Furaha Serventi Blandina Mmbaga, Sylvia Kilenga, Alexi Mremi University of England Jul-19 Jul-21
79 Microbiological characteristics of isolates causing asymptomatic bacteriuria in HIV infected patients attending care and treatment clinic (CTC) at KCMC Hospital Bartholomeo Nicholaus A.K.Mteta THETI-HEPI (PEPFAR) Jul-19 Jul, 2021
80 The spectrum of cancers among people living with HIV in Tanzania: A retrospective hospital-based study Alexi Mremi John Bartlett and Blandina Mmbaga THETI-HEPI (PEPFAR) Jul-19 July, 2021
81 To evaluate the effect of HIV infection and combined antiretroviral therapy on bone turnover markers (BTMS) and bone mineral density in people living with HIV Honest Massawe Furaha Lyamuya and John Bartlett THETI-HEPI (PEPFAR) Jul-19 Ongoing
82 Strengthening caregiver networks to improve youth mental health outcomes Sarah Urasa Neely Myers, Emmanuel Bujulu Jul-19 Jul-21
83 Capacity-building towards the development of a gametocyte based vaccine and gametocyte rapid diagnostic tests Jaffu Chilongola Sixbert Mkumbaye, Pius Horumpende COSTECH Jul-19 Jul, 2021
84 Formative research to assess needs, examine outcomes, and inform future training intervention for Community-based HIV services in Moshi, Tanzania Brandton Kettel Blandina Mmbaga, Melisa Watt Duke Global Health Institute Jul-19 Jul-21
85 Effectiveness of MITS in establishing the cause of death Alexi Mremi Mathew Rubach, Mramba Nyindo, Ronald Mbwasi, Elichilia Shao, Cristina Costales, Blandina Mmbaga MITS surveillance alliance North Carolina, USA Jul, 2019 Jul, 2021
86 Prevalence of Non-Communicable Diseases in Eastern Tanzania Cecilia Bimwenge Judy Kamara, Matilda Mmuya, Elvin Kalongo, Moses Mbugi Tanzania NCD Collaborative Jul, 2019 Jul, 2021
87 Mapping potential entry points of novel HIV interventions in Tanzania John Bales Cheryl L. Dickson, Victor M. Ngowi PHE/US Jul, 2020 Ongoing
88 Genomic profiling of breast cancer patients in Tanzania for effective therapeutic interventions Blandina Mmbaga James G. Njau, Julius Kihungo USAID Aug, 2020 Ongoing
89 Promoting Nutrition Knowledge among Adolescents: The Role of ICT Platforms in Rural Tanzania Mohamed Mwalimu Selina Mzena, Michael J. Paschke UNICEF Dec, 2020 Ongoing
90 A detailed investigation into the effects of malaria on maternal health during pregnancy in Tanzania Anastasia Juma Nancy Mboya, Abdallah Mkumbwa World Bank Jan, 2021 Jan, 2023
91 A pragmatic randomized adaptive clinical trial to investigate controlling alcohol-related harms in a low-income setting: Emergency department brief intervention in Tanzania Blandina Mmbaga Francis Sakita, Kennedy Ngowi, Catherine Staton, Joa0 Ricardo, Nickening Vissoci, Ashler Philips NIH October, 2019 October, 2021
92
93 Urine coulometry for Tuberculosis pharmacokinetics evaluation in Tanzanian children Blandina Mmbaga Estomih Mduma, Vick Farajael, Tania Thomas, Scot Heyshell University of Virginia October, 2019 October, 2021
94 The use of single nucleotide polymorphisms (SNPs) in P.falciparum apicoplast and mitochondria genomes in studying originality and distribution patterns of relevance for surveillance of antimalarial drug resistance in Tanzania Sixbert Mkumbaye Reginald Kavishe, Michael Alifrangis BSU III December, 2019 December, 2021
95 Application of novel molecular technologies for characterization etiology of emerging infectious disease in people presumed with bloodstream infections in Tanzania Shaban Ramadhan Mziray Stella Mpagama, Jaffu Chilongola, Tolbert Sonda EDCTP and NIHER December, 2019 December, 2021
96 Glaucoma Detection Study (GDS)- Detecting glaucoma using a combination of low-cost portable and easily perform the test Einoti Matayan William Makupa, Karin Knoll London School of Hygiene and Tropical Medicine December, 2019 December, 2021
97 Reducing an emerging health threat in Tanzania: Study to examine and assess the seroprevalence, risks, and incidence of Crimean Congo hemorrhagic fever and another zoonotic disease in Tanzania Blandina Mmbaga Ecohealth Programme February, 2020 February, 2021
98 Risk and preventive factors for the development of atopy and asthma in Tanzania (RIPA2TAN) Gissela Nyakunga Blandina Mmbaga, Alice Andongolile, John Shao, Elichilia Shao, Upendo Matoli, David Minja, Nateiya Yongolo, Harald Renzi, Kenny Claus, Chrysanthi Skevaki and Christian Kreisel Philipps, Universit Marburg Mar-20 Mar-21
99 Prevention of antibiotic resistance by TARGETED treatment pneumonia in children Blandina Mmbaga EDCTP April, 2020 Apr-21
100 A model for integrating clinical management of patients with dual tuberculosis and diabetes mellitus in Tanzania Nyasatu Godfrey Chamba Rachel Manongi, Stella Mpagama, Kaushiki Ramaiya, Christian Byberg, Dirk Christensen DANIDA through ADEPT programme June, 2020 June, 2021
101 Optimizing diagnosis and treatment outcomes of dual tuberculosis and diabetes mellitus in Tanzania Kenneth C. Byashalira Blandina Mmbaga DANIDA through ADEPT programme June, 2020 Ongoing
102 IMPAACT P2026S: Pharmacokinetics properties of antiretroviral and antituberculosis drugs during pregnancy and postpartum Pendo Mlay James Ngocho, Boniface Njau NIAD June, 2020 Jul-21
103 Evaluation of the feasibility, accuracy, and effect of a rapid point of care serological triage test for active TB in high burden, HIV endemic African Settings: A multicentre, parallel, group, randomized controlled trial (SeroSELECT) Balthazari Nyombi Carol Hol Hansen, Grant Theron, Kidist Bobosha, Nick Borain, Tim Welsink, Aleksander Jusifoski, Fatima Gruzka NIPH, EDTCP July, 2020 Jul, 2021
104 Comprehensive eye care programme using technology for screening in Northern Tanzania Furahini Mndeme CBM October, 2020 October, 2021
105 Patient’s quality of life, quality of care and treatment outcomes, and family experiences of caring for cancer patients in Tanzania Paulo Lino Kidayi Private (PhD candidate) August, 2020 Aug. 2021
106 A Phase Iib, open-label randomized controlled dose-ranging multicentre trial to evaluate the safety, tolerability, pharmacokinetics, and exposure-response relationship of different doses of sutezoid in combination with bedaquiline, Delamanid and moxifloxacin in adult subjects with newly diagnosed, uncomplicated smear-positive, Drug sensitive Pulmonary Tuberculosis Short title: PANACEA Sutezoloid Dose finding and Combination Evaluation (SUDOCU) Stella Mpagama Blandina Mmbaga, Aliphonce Liyoyo and Peter Mbelele EDCTP November, 2020 November, 2021
107 A randomized double-blind placebo-controlled trial of rifapentine and isoniazid for prevention of tuberculosis in people living with Diabetes in Tanzania and Uganda (PROTID) Nyasatu Godfrey Chamba Kajiru Kilonzo, Hadija Semvua, Blandina Mmbaga, Sweetness Laizer Issa Sabi, Nyanda Ntinginya EDCTP October, 2020 Ongoing
108 Quality of maternal care; risk factors and associated birth outcomes among pregnant women with preeclampsia in Unguja Zanzibar (A Community and Health Facility-based study) Nassra Ishak Yussuf Rachel Manongi, Michael Mahande Ministry of Finance Zanzibar September, 2020 Ongoing
109 The inflammatory and metabolic effect of a 2 weeks food change between traditional Tanzanian and western food change between traditional Tanzanian and western type foods in healthy Tanzanian male individual- DIET study Vesla Kullaya Blandina Mmbaga, Reginald Kavishe, Godfrey Temba, Mary Mosha, Quirjn Mast Andre Van der ven, Joachim L. Schultze, Paolo Lionetti, Mihai Radboud University Medical Centre September, 2020 September, 2021
120 Mortality from Bacteria Infections Resistant to Antibiotics (MBIRA) Tolbert Sonda Happiness Kumburu and Blandina Mmbaga Bill and Melinda Gates Foundation October, 2020 October, 2021
121 One health approach to transboundary disease surveillance and molecular epidemiologic analysis of brucellosis in Tanzania and Rwanda Blandina Mmbaga Jaffu Chilongola, Venance Maro The Defense Threat Reduction Agency October, 2020 Oct-21
122 Phase 11b, open-label, randomized controlled dose ranging multicentre trial to evaluate the safety tolerability, pharmacokinetics and exposure-response relationship of different pelpazolid in combination with bedaquiline, delamanid and moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive drug-sensitive pulmonary Tuberculosis: PANACEA Delpazolid dose-finding and COmbination DEvelopment Stella Mpagama Blandina Mmbaga University Hospital Munich October, 2020 October, 2021
123 STRIPE (Strengthening Inter-Professional HIV Education) Alfred Mteta UCSF Subcontract April 2020 September 2021
124 THRiVE II Sia Msuya African Academy of Sciences
125 EEISHEA (Enhancing Entrepreneurship, Innovation & Sustainability in Higher Education in Africa) Declare Mushi European Union 2018 2021
126 STOP VIOLENCE PROJECT 2 Declare Mushi GIZ/Heidelberg University Germany 2021 2022
127 BSU 3 – Building Stronger University Project Elton Kisanga DANIDA 2017 2021
128 Efficacy of different types of bi-treated long-lasting insecticidal nets and deployment strategy for control of malaria transmitted by pyrethroid-resistant vectors (PAMVERC) Franklin Mosha Global Health Trial: British MRC/ DIFID/WELCOME Trust/LSHTM 2018 2022
129 HEPI/THET (To Reach the People: Transforming Health Professions Education in Tanzania) Alfred Mteta Fogarty Program through Health Professional Education Partnership Initiative (HEPI) 2018 2023
130 SACCAB Michael Mahande Sia Msuya DELTA 2018 2020
131 Strengthen Research Capacity for Junior Faculties in Tanzania(MEPI JF) Alfred Mteta NIH 2016 2020
132 Evaluation of the Feasibility, Accuracy, And Effect of A Rapid Point-of-Care Serological Triage Test for Active TB (SeroSelectTB) in High Burden, HIV-Endemic African Settings: A Multi-Centre, Parallel-Group, Randomized, Controlled Trial Balthazar Nyombi Hadija Semvua EDCTP 2021 2023
133 Predicting vector-borne disease epidemics: Dissemination of risk forecasting using District Health Information Software2 in Tanzania – PreVBD Reginald Kavishe Blandina Mmbaga DANIDA June 2020 May 31 2025
134 Implementing Simulation–Based Education in Malawi and Tanzania (NORHED II) Jane Rogathi Paul Kiday NORAD 2021 2025
135 Use of an Aedes Salivary Biomarker to Assess Arboviral Disease Transmission Risk and Efficacy of Vector Control in North-Eastern Tanzania – SABIOT Debora Kajeguka EDCTP February 2021 February 2023